Certified by Founder Lodge
Elephas
United States - Madison, WI
START UP
1 Disclosed Funding Rounds $55,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Elephas is developing an ex-vivo technology suite to assess how live tumor fragments (LTFs) respond to immunotherapies. We seek to remove the trial-and-error approach to cancer care by harnes
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 24 ,2024 | Series C | $55,000,000 |
ARCH Venture Partners
Sands Capital
Northpond Ventures
Venture Investors
State of Wisconsin Investment Board
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
